NEW YORK (GenomeWeb News) – Precision for Medicine, a Chevy Chase, Md.-based startup offering a variety of services for life science companies, has brought in $150 million in private funding, the firm said this week.

The company is focused on providing bioservices, such as biobanking, biospecimen management, and biomarker identification and validation, as well as consulting and advisory services for firms developing or offering products for "patient-centered, precision medicine."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.